Pluristem to Begin Adult Stem Cell Clinical Trials for Critical Limb Ischemia
Pluristem Therapeutics has announced filing of applications with both the U.S. and European regulatory agencies to initiate clinical trials in the treatment of critical limb ischemia with adult stem cells.